(Rac)-PF-184 是一种有效的 inhibitory factor-κB kinase 2 (IKK-2) 抑制剂,IC50值为 37 nM。(Rac)-PF-184 具有抗炎效果。
生物活性 | (Rac)-PF-184 is a potent inhibitory factor-κB kinase 2 (IKK-2) inhibitor with anIC50of 37 nM. (Rac)-PF-184 has anti-inflammatory effects[1]. |
IC50& Target | |
体外研究 (In Vitro) | (Rac)-PF-184 has slow dissociation kinetics with a T1/2of 6.7 h from rhIKK-2, very low oral bioavailability (5%), high intravenous clearance (59 ml/min/kg), and high P450 metabolism in human liver microsomes[1]. (Rac)-PF-184 binds tightly to endogenous IKK-2 and shows extended inhibition of kinase activity and cytokine production[1]. (Rac)-PF-184 shows a concentration-dependent inhibition on LPS- and IL-1β-induced production of inflammatory mediators in a variety of human disease-relevant cells[1]. (Rac)-PF-184 (0.001-10 μM, 1 h) inhibits IL-1β-induced TNF-α in a concentration-dependent manner with maximal efficacies of 94% and relative potencies of 163 nM[1]. (Rac)-PF-184 inhibits LPS-induced cytokine production from rat alveolar macrophages and blocked p65 nuclear translocation[1].
|
体内研究 (In Vivo) | (Rac)-PF-184 (0.3-2.5 mg; i.t.; once) blocks neutrophil infiltration and BAL cell cytokine production[1].
Animal Model: | Fasted male Sprague-Dawley rats (350 g) placed into a chamber connected to a large volume nebulizer filled with 20 ml of 1 mg/mL solution of LPS[1] | Dosage: | 0.3-2.5 mg | Administration: | Nano suspension and administered intratracheally in a volume of 100 μL, 60 min before aerosolized LPS | Result: | Resulted in a comparable attenuation of total cell and PMN cell infiltration 4 h after LPS exposure. Dose-dependently inhibited cell infiltration with EC50values of 1 mg. Dose-dependently suppressed BAL fluid TNF- and PGE2 levels comparable with cell infiltration. Inhibited p65 translocation. Showed long-lasting activity. |
|
分子量 | |
Formula | |
CAS 号 | |
运输条件 | Room temperature in continental US; may vary elsewhere. |
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |